Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

ICOS Corp

Article Abstract:

ICOS Dir Frank T. Cary acquired 3,000 shares last Nov 16, 1992, raising his interest to 18,000 shares. This single action deserves consideration since Cary has reliable trading timing. Chmn George B. Rathmann, former Amgen president, reportedly has 300,000 ICOS shares. Walter Wriston of Citicorp and William Gates of Microsoft are both ICOS directors with the latter having 1,852,222 shares. Cary's trading performance and the prominent board of directors indicate positive signs.

Publisher: Thomson Financial Inc.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1993
Biological products exc. diagnostic, Biotechnology industry, Biotechnology industries, ICOS Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Calgene Inc

Article Abstract:

Calgene Inc is engaged in portfolio development of genetically engineered plants and plant products. The stock appreciated from the $12 to $13 range to $20.63 by late 1992 but no insider selling was seen as the high. Three insiders cleared out 24,000 shares as price lingered at the $12.50 to $13.50 range. Insider distribution during a declining price suggests a lack of positive fundamentals.

Publisher: Thomson Financial Inc.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1993
Patent owners and lessors, Plant products industry, Calgene L.L.C.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Securities
Similar abstracts:
  • Abstracts: Comair Holdings Inc. AMR Corp. AirTran Corp
  • Abstracts: Conner Peripherals Inc. EMC Corp
  • Abstracts: Adaptec Inc. Franklin Electronic Publishers
  • Abstracts: Rowan Companies Inc. Helmerich & Payne Inc
  • Abstracts: Sovereign Bancorp Inc. Greater New York Savings Bank. Rochester Community Savings
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.